Go Back
Catalio Capital Management
Catalio Capital Management, a Venture Fund founded in 2016, is located in Baltimore, Maryland. The fund, led by Partner John Henry Iucker, invests in Pre-Seed, Seed, and Series A stages. With a focus on BioTech, Healthcare, Life Science, Pharmaceuticals, AI/ML, Software, Medical Device, and Big Data & Analytics, Catalio Capital Management has invested in companies like Celsius Therapeutics, Xilis, and Sherlock Biosciences. They have made 35 investments and seen 5 exits in breakthrough biomedical technology companies. For more information, visit their website at www.cataliocapital.com.
About
About
About
Bio
Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.
Location
Baltimore, Maryland
Stage
Pre-Seed, Seed, Series A
Partner name
John Henry Iucker
Bio
Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.
Location
Baltimore, Maryland
Stage
Pre-Seed, Seed, Series A
Partner name
John Henry Iucker
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Life Science, Pharmaceuticals, Artificial Intelligence & Machine Learning (AI/ML), Software, Medical Device, Big Data & Analytics
Number of investments
35
Number of exits
5
Fund Type
Venture Fund
Portfolio Companies
Celsius Therapeutics, Xilis, Sherlock Biosciences, Entos, Paige, Cambrian Biopharma, Satellite Bio, Personal Genome Diagnostics
Catalio Capital Management
Catalio Capital Management, a Venture Fund founded in 2016, is located in Baltimore, Maryland. The fund, led by Partner John Henry Iucker, invests in Pre-Seed, Seed, and Series A stages. With a focus on BioTech, Healthcare, Life Science, Pharmaceuticals, AI/ML, Software, Medical Device, and Big Data & Analytics, Catalio Capital Management has invested in companies like Celsius Therapeutics, Xilis, and Sherlock Biosciences. They have made 35 investments and seen 5 exits in breakthrough biomedical technology companies. For more information, visit their website at www.cataliocapital.com.
About
Bio
Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.
Location
Baltimore, Maryland
Stage
Pre-Seed, Seed, Series A
Partner name
John Henry Iucker
Fund
Fund Focus
BioTech, Healthcare, Life Science, Pharmaceuticals, Artificial Intelligence & Machine Learning (AI/ML), Software, Medical Device, Big Data & Analytics
Number of investments
35
Number of exits
5
Fund Type
Venture Fund
Portfolio Companies
Celsius Therapeutics, Xilis, Sherlock Biosciences, Entos, Paige, Cambrian Biopharma, Satellite Bio, Personal Genome Diagnostics